Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats

Y Ren, J Jiang, W Jiang, X Zhou, W Lu, J Wang… - Neurochemical …, 2021 - Springer
Brain inflammation induced by ischemic stroke is an important cause of secondary brain
injury. The nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and …

Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats

R Yikun, J Jiang, J Wenxia, Z Xueling… - Neurochemical …, 2021 - search.proquest.com
Brain inflammation induced by ischemic stroke is an important cause of secondary brain
injury. The nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and …

Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats

Y Ren, J Jiang, W Jiang, X Zhou… - Neurochemical …, 2021 - pubmed.ncbi.nlm.nih.gov
Brain inflammation induced by ischemic stroke is an important cause of secondary brain
injury. The nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and …

Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats.

Y Ren, J Jiang, W Jiang, X Zhou, W Lu… - Neurochemical …, 2021 - europepmc.org
Brain inflammation induced by ischemic stroke is an important cause of secondary brain
injury. The nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and …

Spata2 Knockdown Exacerbates Brain Inflammation via NF-κB/P38MAPK Signaling and NLRP3 Inflammasome Activation in Cerebral Ischemia/Reperfusion Rats.

Y Ren, J Jiang, W Jiang, X Zhou, W Lu… - Neurochemical …, 2021 - search.ebscohost.com
Brain inflammation induced by ischemic stroke is an important cause of secondary brain
injury. The nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and …